Safety and Efficacy of Peptide Receptor Radionucleotide Therapy (PRRT) in Metastatic Neuroendocrine Tumors: A US Single-Institution Experience Post-FDA ApprovalE. A. Strong, M. Gracz, A. Livingston,S. Tsai,K. Christians,B. George,P. Ritch, D. B. Evans,Y. Wong,J. P. Thomas,C. N. ClarkeANNALS OF SURGICAL ONCOLOGY（2020）引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
